Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: LindyBill who wrote (19389)	5/29/2012 10:25:30 PM
From: rich evans	Read Replies (4) \| Respond to of 39297

Stop your statins? Low Cholesterol Linked To Elevated Cancer Risk New data from the Framingham Heart Study finds that low LDL-cholesterol is related to the future development of cancer. Scientists studied 201 participants with cancer who were matched with 201 controls who were cancer free. The researchers looked at the trend of LDL-cholesterol for an extended period of time prior to cancer diagnosis, using data taken at four points over an average of 18.7 years prior to diagnosis. They found that LDL-cholesterol levels were lower in the participants with cancer than their matched controls at each of the data points. As compared to the cancer-free subjects, the trend of low LDL-cholesterol in those who developed cancer was consistent throughout the period of the study. (Medicalnewstoday.com 3.27.2012) This is another, in an ever-growing number of studies showing an association between low cholesterol (including LDL-cholesterol) and cancer development. The AMA and most cardiologists have been beating the drum claiming that we need to lower cholesterol levels down to numbers only obtainable through the use of medications such as statin drugs. However, they don’t inform the public that there is a risk to lowering cholesterol levels. One risk is developing cancer. Another risk is poor immune system function since cholesterol helps the cells maintain their integrity. Also, lowering cholesterol to miniscule levels will worsen toxicity symptoms as cholesterol helps to buffer toxicities in the body. One of the highest levels of cholesterol in the body is in the brain. It doesn’t take a rocket scientist to predict that lowered cholesterol levels would be associated with brain disorders. In fact, lowered cholesterol levels (and LDL-cholesterol levels) have been associated with the development of neurological disorders such as Parkinson’s and Alzheimer’s disease. Cholesterol-lowering medications are overused. There is no known benefit of these medications in the elderly as lowered cholesterol levels predict a shorter lifespan in this population. If you have not had a stroke or a heart attack, there is no known benefit of a statin drug. Women have never been shown to benefit from taking a statin drug. The only benefit that statins have been shown to provide is for patients who have already suffered a cardiac event—patients who have previously had a heart attack or a stroke. In this case, the research shows a slight reduction in non-fatal heart attacks (approximately 1%) after three years of use.